1.14.14.14 adrenal gland maternal ovaries and adrenals maintain high aromatase activity throughout gestation 745021 1.14.14.14 brain Cyp19a1b is solely detected at putative radial glial cells of the forebrain, close to the brain ventricles 745054 1.14.14.14 brain high transcript abundance in the female brain, followed by gonads, liver, gill, kidney and muscle 745022 1.14.14.14 brain high transcript abundance in the ovary and female brain, followed by the testis and male brain, and female liver and muscle 745022 1.14.14.14 brain higher aromatase expression in female compared with male cerebral vessels 743990 1.14.14.14 brain male brain aromatase activity is signficantly increased by treatments with estradiol or ethynylestradiol while female brain aromatase activity is unaffected 744150 1.14.14.14 C6 glioma cell cell line expresses aromatase mRNA and shows a cytoplasmic pattern of aromatase immunoreactivity. In addition, the cell line expresses estrogen receptor alpha 726047 1.14.14.14 cytotrophoblast villous cytotrophoblast cells 764239 1.14.14.14 embryo aromatase activity in the developing brains and gonads of embryos is comparable with measurements in oviparous reptiles. Aromatase activity in the embryonic gonads is low at embryonic stage 29-34, but increases significantly at mid-development and then remains high in late stage embryos 745021 1.14.14.14 glioma cell - 726047 1.14.14.14 gonad - 744150 1.14.14.14 gonad high transcript abundance in the female brain, followed by gonads, liver, gill, kidney and muscle 745022 1.14.14.14 HMF3A cell - 765383 1.14.14.14 hypothalamus AROM and NOS proteins are coexpressed with NADPH oxidase in the preoptic-anterior hypothalamus 764772 1.14.14.14 hypothalamus in the female, activity is detecable throughout the year 745062 1.14.14.14 JAR cell trophoblastic tumor cell of placenta -, 725174 1.14.14.14 JEG-3 cell - 765130 1.14.14.14 liver high transcript abundance in the female brain, followed by gonads, liver, gill, kidney and muscle 745022 1.14.14.14 liver high transcript abundance in the ovary and female brain, followed by the testis and male brain, and female liver and muscle 745022 1.14.14.14 MCF-7 cell - 764633, 765383, 765426 1.14.14.14 additional information brain aromatase expression does not differ between types of males, but pituitary Cyp19a1b expression levels positively correlate with the index of agonistic behavior 745054 1.14.14.14 additional information Cyp19a1b expression is higher in females than males 745022 1.14.14.14 muscle high transcript abundance in the female brain, followed by gonads, liver, gill, kidney and muscle 745022 1.14.14.14 muscle high transcript abundance in the ovary and female brain, followed by the testis and male brain, and female liver and muscle 745022 1.14.14.14 NIH-3T3 cell - 765426 1.14.14.14 ovary - 724244, 744946 1.14.14.14 ovary activity is found only during vitellogenesis. At the completion of vitellogenesis, ovarian aromatase activity declines sharply resulting in elevation of plasma testosterone levels 745062 1.14.14.14 ovary highest signal intensity 745022 1.14.14.14 ovary increases in aromatase activities of the ovary and testis precede the onset of the ovarian and testicular development. Aromatase activities reach the highest level at the growing stage in February and the mature stage in March, and show a striking decrease at the spawning stage in April. Contents of ovarian and testicular estradiol-17beta change similarly to the profile of aromatase activities in the ovary and testis, although estrone shows no change 724783 1.14.14.14 ovary maternal ovaries and adrenals maintain high aromatase activity throughout gestation 745021 1.14.14.14 ovary ovarian aromatase activity is significantly decreased by treatments with estradiol or ethynylestradiol 744150 1.14.14.14 placenta - 724158, 724244, 725325, 725327, 725329, 725832, 726036, 744512, 764239, 765220, 765542 1.14.14.14 placenta during the early phases of embryonic development, placental aromatase activity is comparable to that in maternal ovaries, but declines significantly at progressive stages of gestation 745021 1.14.14.14 SAOS-2 cell - 745452 1.14.14.14 T-98G cell cell line expresses aromatase mRNA and shows a cytoplasmic pattern of aromatase immunoreactivity. In addition, the cell line expresses estrogen receptor alpha 726047 1.14.14.14 testis high transcript abundance in the ovary and female brain, followed by the testis and male brain, and female liver and muscle 745022 1.14.14.14 testis immunoreactivities against aromatase and estradiol-17beta are detected in the cells along the inside of the acinar wall of the testis 724783 1.14.14.14 U-373MG cell cell line expresses aromatase mRNA and shows a cytoplasmic pattern of aromatase immunoreactivity. In addition, the cell line expresses estrogen receptor alpha 726047 1.14.14.14 ZR-75-1 cell - 765383